Breaking news

Scientific Publication

Fluofarma is glad to announce a new scientific publication in the journal Cell Research:

Outer membrane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis

Flora Tomaselloa,b, Angela Messinab,c, Lydia Lartiguea, Laura Schembria, Chantal Medinaa, Simona Reinab,c, Didier Thoravald, Marc Crouzetd, François Ichasa,e, Vito De Pintob,c and Francesca De Giorgia,e

a INSERM U916, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France
b Dipartimento Scienze Chimiche, Università di Catania, Catania, Italia
c Istituto Nazionale di Biomembrane e Biosistemi, Sezione di Catania, Roma, Italia
d CNRS UMR 5095, Université Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
e Fluofarma, 2 rue Robert Escarpit, 33600 Pessac, France

Abstract:
Voltage-dependent anion channel (VDAC)1 is the main channel of the mitochondrial outer membrane (MOM) and it has been proposed to be part of the permeability transition pore (PTP), a putative multiprotein complex candidate agent of the mitochondrial permeability transition (MPT). Working at the single live cell level, we found that overexpression of VDAC1 triggers MPT at the mitochondrial inner membrane (MIM). Conversely, silencing VDAC1 expression results in the inhibition of MPT caused by selenite-induced oxidative stress. This MOM-MIM crosstalk was modulated by Cyclosporin A and mitochondrial Cyclophilin D, but not by Bcl-2 and Bcl-xl, indicative of PTP operation. VDAC1-dependent MPT engages a positive feedback loop involving reactive oxygen species and p38-MAPK, and secondarily triggers a canonical apoptotic response including Bax activation, cytochrome c release and caspase 3 activation. Our data thus support a model of the PTP complex involving VDAC1 at the MOM, and indicate that VDAC1-dependent MPT is an upstream mechanism playing a causal role in oxidative stress-induced apoptosis.

Cell Research advance online publication 11 August 2009; doi: 10.1038/cr.2009.98

Back to the list

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • ECCP 2010

    Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.

    Read more [+]

  • BIO-Connexion Congress

    Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.

    Read more [+]

  • 22nd EORTC-NCI-AACR symposium

    Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS